Teva Pharmaceutical Industries stock Analysis: 60% Upside Despite Bearish Chart
Teva Pharmaceutical Industries stock closed at $30.81on July 24, sitting below key moving averages. Wall Street analysts project over 60% upsidewith a 100% buy rating. The daily chart, however, is not confirming that optimism. The gap between bullish narratives and technical weakness defines TEVAs current tension. TEVA — daily chart with candlesticks, EMA20/EMA50 and volume.Key takeawaysTEVA closed at $30.81on July 24, below the daily EMA20 at $32.17 and EMA50 at $32.81The EMA200 at $29.94serves as the critical structural floor that must hold for any recoveryDaily RSI at 40.15 reflects weak momentum, while the MACD confirms persistent downward pressureWall Street analysts maintain a 100% buy rating with price targets implying over 60% upsideThe hourly MACD histogram shows a slight positive divergence, hinting at fading selling pressure near current levels Daily Timeframe: Bearish Pressure Beneath the Surface The daily chart leans bearishdespite an official neutral regime reading. Price sits below both the EMA20 and EMA50, with only the EMA200 providing structural support. Momentum Indicators Confirm Downward Pressure Meanwhile, the daily RSI at 40.15 places TEVA in weak territory. It is not yet oversold, but it is approaching the zone where momentum shifts become possible. The MACD line at -0.75 sits below its signal line at -0.54. The